GENEVA: WHO experts have voiced"very low confidence" in data provided by Chinese state-owned drugmaker Sinopharm on its COVID-19 vaccine regarding the risk of serious side-effects in some patients, but overall confidence in its ability to prevent the disease, a document seen by Reuters shows.
The document includes summaries of data from clinical trials in China, Bahrain, Egypt, Jordan and the United Arab Emirates. But it added:"Analysis of safety amongst participants with comorbidities limited by the low number of participants with comorbidities in the Phase 3 trial."
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.